Drug eruption following high-calorie infusion: a possible systemic type IV allergic reaction to sulphites.
نویسندگان
چکیده
© 2015 The Authors. doi: 10.2340/00015555Journal Compilation © 2015 Acta Dermato-Venereologica. ISSN 0001-5555 Sulphites, such as sodium bisulphite and sodium metabisulphite, are widely used as antioxidants or preservatives in a wide range of substances, such as food, cosmetics and medications (1). It has been reported that sulphite intake can cause systemic type I allergic reactions, such as urticaria (2) and anaphylaxis (3, 4). In addition, external application of sulphites can cause local type IV allergic reactions, such as contact dermatitis (1, 5). However, it is not known whether sulphite intake can cause systemic type IV allergic reactions. We describe here a case of drug eruption, thought to be a systemic type IV allergic reaction to sulphites, following a high-calorie infusion.
منابع مشابه
A Rare Case of Fixed Drug Eruption due to Ondansetron
AbstractFixed drug eruption (FDE) is a unique type of cutaneous drug reaction that typically recurs in the identical locations on re-exposure to the attributed drug. FDE is characterized by the appearance of a single or multiple sharply demarcated violaceous erythematous plaques which heal with residual hyperpigmentation. A 27-year-old woman presented with multiple dark patches over her eyelids...
متن کاملAllergic contact dermatitis from a topical corticosteroid mimicking acute generalized exanthematous pustulosis.
Sir, Acute generalized exanthematous pustulosis (AGEP) designates an uncommon, cutaneous reaction characterized by an acute eruption of numerous, small, mostly non-follicular sterile pustules arising on a widespread oedematous erythema; fever above 38 C̊; blood neutrophil count above 7610/l and spontaneous resolution of pustules within 15 days. Typical histopathological findings are subcorneal a...
متن کاملDelayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.
BACKGROUND Natalizumab is a new therapeutic option for relapsing-remitting multiple sclerosis. As with other antibody therapies, hypersensitivity reactions have been observed. In the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) trial, infusion-related hypersensitivity reactions developed in 4% of patients, usually within 2 hours after starting the infusion....
متن کاملPrevalence of Cutaneous Drug Eruption in Hospitalized Patients: A Report from Sina Hospital of Tabriz
Background: Cutaneous drug reaction seems to be relatively common The aim of the study was to recognize offending drugs, evaluate patients' characteristics and educate the patients to avoid selfadministration and re-administration of drugs. Methods: We retrospectively and prospectively analyzed data from Sina hospital in Tabriz (2000-2005) to determine the number of hospitalizations and visits ...
متن کاملFluconazole - a case report on fixed drug eruption
Background Adverse reactions to drugs, Fixed Erythema (FE), correspond to 16-21% of all skin eruptions. This disease results in the development of one or more erythematous annular or oval, plaques as a result of systemic exposure to a drug. On reexposure relapse occurs in the same place, although new lesions may arise simultaneously in other areas. Any drug can cause FE. The physiopathology inv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Acta dermato-venereologica
دوره 95 7 شماره
صفحات -
تاریخ انتشار 2015